> Educational Content Only: This compound is discussed for educational purposes only and is not currently offered by our company. AOD-9604 (Advanced Obesity Drug) is a synthetic peptide fragment corresponding to amino acids 177-191 of human growth hormone (hGH). Developed by Metabolic Pharmaceuticals in Australia, this modified peptide was designed to retain the lipolytic (fat-burning) properties of growth hormone while eliminating the growth-promoting and diabetogenic effects. - Molecular Weight: 1,815 Da - Amino Acid Sequence: hGH fragment 177-191 with tyrosine substitution - Modification: C-terminal tyrosine added to enhance stability - Structure: Linear peptide fragment - Solubility: Water-soluble AOD-9604 operates through a distinct mechanism from intact growth hormone: - Beta-3 Adrenergic Receptor Interaction: May enhance beta-3 receptor sensitivity - Adipocyte Targeting: Specifically affects adipose tissue metabolism - No IGF-1 Elevation: Does not stimulate insulin-li
AOD-9604: Metabolic Peptide Research Guide
Explore AOD-9604, a modified growth hormone fragment with lipolytic properties. Learn about its mechanism of action, research applications in metabolic studies, and key scientific findings.